SCHEMBL7191864

SCHEMBL7191864

COc1c(O)c(C=CC(=O)c2ccccc2)c(OC)c(OC)c1OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 2/20 0.53
▸ ABCG2 Q9UNQ0 2/20 0.49
▸ PTPN1 P18031 1/20 0.47
▸ LMNA P02545 2/20 0.45
▸ HPGD P15428 1/20 0.45
▸ CYP3A4 P08684 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ TNFRSF1A P19438 2/20 0.44
▸ APP P05067 1/20 0.44
▸ BCHE P06276 2/20 0.44
▸ NFKB1 P19838 1/20 0.44
▸ NFKB2 Q00653 1/20 0.44
▸ RELA Q04206 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ PDE4A P27815 1/20 0.43
▸ PDE4B Q07343 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7191857 1.00 MAOB (0.53) MAOBABCG2PTPN1LMNAHPGD
SCHEMBL7197500 0.89 BCHE (0.54) MAOBABCG2LMNACYP3A4CYP1A2
SCHEMBL7197497 0.89 BCHE (0.54) MAOBABCG2LMNACYP3A4CYP1A2
SCHEMBL679431 0.85 TNFRSF1A (0.59) PTPN1HPGDTNFRSF1AAPPNPC1
SCHEMBL8066940 0.81 PTPN1 (0.55) MAOBABCG2PTPN1LMNAHPGD
SCHEMBL28022176 0.81 BCHE (0.54) MAOBABCG2LMNACYP3A4CYP1A2
SCHEMBL28140741 0.81 MAPT (0.52) MAOBABCG2LMNACYP3A4CYP1A2
SCHEMBL8146123 0.80 MAPT (0.59) MAOBABCG2LMNAHPGDCYP3A4
SCHEMBL5084928 0.79 CYP3A4 (0.49) MAOBABCG2LMNACYP3A4CYP1A2
SCHEMBL22806733 0.78 BCHE (0.54) MAOBABCG2LMNACYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones STATENS SERUM INSTITUTE (DK) 2003-04-03 — — US claimed
EP-0996432-A2 BIOLOGICALLY ACTIVE 1,3-BIS-AROMATIC-PROP-2-EN-1-ONES, 1,3-BIS-AROMATIC-PROPAN-1-ONES, AND 1,3-BIS-AROMATIC-PROP-2-YN-1-ONES STATENS SERUMINSTITUT (DK) 2000-05-03 — — EP claimed
WO-1999000114-A2 BIOLOGICALLY ACTIVE 1,3-BIS-AROMATIC-PROP-2-EN-1-ONES, 1,3-BIS-AROMATIC-PROPAN-1-ONES, AND 1,3-BIS-AROMATIC-PROP-2-YN-1-ONES STATENS SERUM INSTITUT (DK) 1999-01-07 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones AKR1C3, AKR1C1, AKR1A1 MAOB 943/4885ABCG2 1177/4885PTPN1 872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback